Trials / Sponsors / GOG Foundation
GOG Foundation
Network · 17 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | A Study of Alpelisib and Fulvestrant to Treat Endometrial Cancer Endometroid Endometrial Cancer | Phase 2 | 2024-09-11 |
| Recruiting | Letrozole in Uterine Leiomyosarcoma Uterine Leiomyosarcoma | Phase 2 | 2024-07-17 |
| Recruiting | Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube C Stage III Ovarian Cancer, Stage IV Ovarian Cancer, Stage III Primary Peritoneal Cancer | Phase 3 | 2024-03-08 |
| Recruiting | A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer Cervical Cancer | N/A | 2022-03-22 |
| Completed | Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer Advanced, Persistent, or Recurrent Endometrial Cancer | Phase 2 | 2015-05-21 |
| Active Not Recruiting | Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma | N/A | 2013-06-05 |
| Completed | Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia Choriocarcinoma, FIGO Stage I Gestational Trophoblastic Tumor, FIGO Stage II Gestational Trophoblastic Tumor | Phase 3 | 2012-06-18 |
| Completed | Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced C Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified | Phase 3 | 2012-01-09 |
| Completed | Bevacizumab With or Without Everolimus in Treating Patients With Recurrent or Persistent Ovarian Epithelial Ca Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma | Phase 2 | 2010-12-27 |
| Completed | Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma | Phase 2 | 2010-12-13 |
| Completed | Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Und Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Not Otherwise Specified | Phase 3 | 2010-04-12 |
| Unknown | Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Ovarian Granulosa Cell Tumor, Ovarian Gynandroblastoma, Ovarian Sertoli-Leydig Cell Tumor | Phase 2 | 2010-02-08 |
| Unknown | Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Ut Mixed Mesodermal (Mullerian) Tumor, Ovarian Carcinosarcoma, Recurrent Fallopian Tube Carcinoma | Phase 3 | 2009-08-17 |
| Active Not Recruiting | CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical C Atypical Endometrial Hyperplasia, Human Papillomavirus Infection, Stage 0 Cervical Cancer AJCC v7 | N/A | 2009-04-13 |
| Unknown | Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation, Endometrial Mucinous Adenocarcinoma, Endometrial Squamous Cell Carcinoma | Phase 2 | 2008-02-25 |
| Unknown | Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian E Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma | Phase 3 | 2005-03-21 |
| Completed | Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With S Recurrent Uterine Corpus Carcinoma, Stage IIIA Uterine Corpus Cancer AJCC v7, Stage IIIB Uterine Corpus Cancer AJCC v7 | Phase 3 | 2003-08-25 |